Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin-dependent diabetic patients

Journal of Hypertension

Volumn 15, Issue 2, 1997, Pages 191-196

  Earle, Kenneth A ^a,b   Morocutti, Anna ^a   Viberti, GianCarlo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Blood pressure; Insulin dependent; Proteinuria

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LITHIUM; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; ERYTHROCYTE; FAMILY HISTORY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; SODIUM TRANSPORT;

EID: 0031052390     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715020-00010     Document Type: Article

References (33)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
2. 2 microglobulin in insulin-dependent diabetes. N Engl J Med 1979, 300:638-641.
3. Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1985, 311:365-372.
4. Microalbuminuria Collaborative Study Group, United Kingdom: Intensive therapy and progression to clinical albuminuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. BMJ 1995, 311:975-976.
5. Diabetes Control and Complications (DCCT) Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 1995, 42:1703-1720.
6. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. N Engl J Med 1989, 320:1161-1165.
7. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, et al.: Is diabetic nephropathy an inherited complication? Kidney Int 1992, 41:719-722.
8. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T: Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 1990, 39:245-249.
9. Microalbuminuria Collaborative Study Group: Risk factors for development of microalbuminuria in insulin-dependent diabetic patients; a cohort study. BMJ 1993, 306:1235-1239.
10. Barzilay J, Warram J, Bak M, Laffel LMB, Canessa M, Krolewski AS: Predisposition to hypertension is a major risk factor for the development of advanced nephropathy and hypertension during the first 20 years of IDDM. Kidney Int 1992, 41:723-730.
11. Mogensen CE: Long term anti-hypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982, 285:685-688.
12. Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 1987, 294:1443-1447.
13. Mangili R, Bending JJ, Scott G, Li K, Gupta A, Viberti GC: Increased sodium-lithium countertransport activity in red blood cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988, 318:146-150.
14. Earle K, Walker J, Hill C, Viberti GC: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992, 326:673-677.
15. Rose GA: Chest pain questionnaire. Milbank Memorial Fund Q 1965, 43 (Part 2):32.
16. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980, 302:772-776.
17. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
18. Nelson RG, Pettit DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, et al.: Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993, 36:998-1001.
19. Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993, 42:715-719.
20. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effects of enalpril in diabetic nephropathy. BMJ 1992, 304:339-343.
21. Brazy PC, Staed WW, Fitzwilliam JF: Progression of renal insufficiency: role of blood pressure. Kidney Int 1989, 35:670-667.
22. Oldrizzi L, Rugiu C, Maschio G: Hypertension and progression of renal failure in patients on protein-restricted diet. Contr Nephrol 1987, 54:134-143.
23. Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, et al. and the Northern Italian Cooperative Study Group: Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrol Dial Transplant 1996, 11:461-467.
24. Klahr S, Levy AS, Beck GJ, Cagguila AW, Hunsicker L, Kuseck JW: The effect of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994, 330:877-884.
25. Kontessis PS, Friedman R, Tariq T, Moro F, Williams DG, Hartley RB, et al.: Sodium lithium countertransport activity as a determinant of deterioration of glomerular function in IgA nephropathy. Exp Nephrol 1994, 2:176-181.
26. Feldt-Rasmussen B, Mathiesen E, Deckert T: Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986, ii:1300-1304.
27. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T: Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991, 34:164-170.
28. Bending JJ, Viberti GC, Watkins PJ, Keen H: Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. BMJ 1986, 292:83-86.
29. Fioretto P, Steffes MW, Mauer M: Glomerular structure in non-proteinuric IDDM patients with various levels of albuminuria. Diabetes 1994, 43:1358-1364.
30. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type 1 diabetes without overt proteinuria. N Engl J Med 1989, 320:966-970.
31. Cambien F, Poirer O, Leceref I, Evans A, Cambien JP, Arvelu D, et al.: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 35:641-644.
32. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo, et al.: Association between angiotensin converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996, 347:94-95.
33. Jacobsen P, Tarnow L, Rossing P, Cambien F, Lecerf L, Poirier O, et al.: The insertion/deletion (I/D) polymorphism in the angiotensin-1-converting enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACE1) in insulin dependent diabetic (IDDM) patients. J Am Soc Nephrol 1995, 6:450.